Parexel and Veeva Partner Aim to Accelerate Clinical Trials
Parexel and Veeva Systems have announced a collaboration to accelerate clinical trials through technology and process innovation. The collaboration combines each company’s experience across thousands of studies worldwide.
As part of the partnership, Parexel is standardizing on Veeva’s suite of clinical operations applications, including Veeva Vault eTMF, Vault CTMS, and Vault Study Startup. Veeva Vault CDMS for clinical data management will also become a standard offering available from Parexel to its customers.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025